β-alanine Supplementation on Knee Extensor Contractile and Force Properties
Launched by NOTTINGHAM TRENT UNIVERSITY · Jun 27, 2016
Trial Information
Current as of May 21, 2025
Completed
Keywords
ClinConnect Summary
Carnosine (β-alanyl-L-histidine) is a naturally occurring dipeptide formed by bonding histidine and β-alanine in a reaction catalysed by carnosine synthase. One role of carnosine within the human system, is as an intracellular pH buffer due to its pKa of 6.83. Carnosine is suitable over the whole exercise induced intramuscular pH transit-range. Carnosine in untrained populations can neutralise 2.4 to 10.1mmol H+.kg-1 of dry mass muscle as intramuscular pH declines, adding at least 7% to 10% to total intramuscular buffering capacity. It has also been argued that carnosine in combination with...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • physically active
- • male
- Exclusion Criteria:
- • vegetarian/vegan
- • have been using β-alanine or carnosine supplements within the past 6 months
- • Bone disorders in the assessed lower limb, sustained within the previous 2 years, including osteoarthritis, osteoporosis, bone cyst and osteopenia.
- • Non-arthroscopic joint surgery, or joint replacement, ever, in the assessed limb (knee, hip and ankle).
- • Lower limb leg injuries including sprains and strains, joint dislocations and fractures.
- • Regular knee pain in the assessed limb when performing daily movement tasks.
- • Participation within a resistance training programme in the last 6 months
About Nottingham Trent University
Nottingham Trent University (NTU) is a prominent higher education institution in the UK, renowned for its commitment to advancing research and innovation across various disciplines, including healthcare and clinical trials. With a strong emphasis on interdisciplinary collaboration, NTU leverages its expertise in health sciences to design and conduct rigorous clinical studies aimed at improving patient outcomes and informing public health strategies. The university fosters a dynamic research environment, utilizing state-of-the-art facilities and methodologies to ensure ethical standards and scientific integrity in all its clinical trial endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials